238 related articles for article (PubMed ID: 33200913)
1. The deregulation of NOTCH pathway, inflammatory cytokines, and keratinization genes in two Dowling-Degos disease patients with hidradenitis suppurativa.
Cortez Cardoso Penha R; Cortez de Almeida RF; Câmara Mariz J; Brewer Lisboa L; do Nascimento Barbosa L; Souto da Silva R
Am J Med Genet A; 2020 Nov; 182(11):2662-2665. PubMed ID: 33200913
[TBL] [Abstract][Full Text] [Related]
2. [Dowling-Degos disease and chronic hidradenitis suppurativa].
Rammeh Rommani S; Ajouli W; Fazaa B; Khaled A; Zermani R
Ann Dermatol Venereol; 2013 Dec; 140(12):838-40. PubMed ID: 24315237
[No Abstract] [Full Text] [Related]
3. Dowling-Degos disease associated with hidradenitis suppurativa: a case report.
Arjona-Aguilera C; Linares-Barrios M; Albarrán-Planelles C; Jiménez-Gallo D
Actas Dermosifiliogr; 2015 May; 106(4):337-8. PubMed ID: 25529465
[No Abstract] [Full Text] [Related]
4. A phenotype combining hidradenitis suppurativa with Dowling-Degos disease caused by a founder mutation in PSENEN.
Pavlovsky M; Sarig O; Eskin-Schwartz M; Malchin N; Bochner R; Mohamad J; Gat A; Peled A; Hafner A; Sprecher E
Br J Dermatol; 2018 Feb; 178(2):502-508. PubMed ID: 28922471
[TBL] [Abstract][Full Text] [Related]
5. Hidradenitis suppurativa, Dowling-Degos and multiple epidermal cysts: a new follicular occlusion triad.
Loo WJ; Rytina E; Todd PM
Clin Exp Dermatol; 2004 Nov; 29(6):622-4. PubMed ID: 15550138
[TBL] [Abstract][Full Text] [Related]
6. A loss-of-function NCSTN mutation associated with familial Dowling Degos disease and hidradenitis suppurativa.
de Oliveira ASLE; de Siqueira RC; Nait-Meddour C; Tricarico PM; Moura R; Agrelli A; d'Adamo AP; Jamain S; Crovella S; de Fátima Medeiros Brito M; Boniotto M; Brandão LAC
Exp Dermatol; 2023 Nov; 32(11):1935-1945. PubMed ID: 37665193
[TBL] [Abstract][Full Text] [Related]
7. Mutations in γ-secretase subunit-encoding PSENEN underlie Dowling-Degos disease associated with acne inversa.
Ralser DJ; Basmanav FB; Tafazzoli A; Wititsuwannakul J; Delker S; Danda S; Thiele H; Wolf S; Busch M; Pulimood SA; Altmüller J; Nürnberg P; Lacombe D; Hillen U; Wenzel J; Frank J; Odermatt B; Betz RC
J Clin Invest; 2017 Apr; 127(4):1485-1490. PubMed ID: 28287404
[TBL] [Abstract][Full Text] [Related]
8. Dowling-Degos disease: a review.
Stephan C; Kurban M; Abbas O
Int J Dermatol; 2021 Aug; 60(8):944-950. PubMed ID: 33368260
[TBL] [Abstract][Full Text] [Related]
9. Dowling-Degos Disease Presenting With Associated Epidermal Inclusion Cysts: A Case Report and Review of the Literature.
Marinelli KC; Marinelli LM; Roberts AM; Lincoln MS
Am J Dermatopathol; 2022 Mar; 44(3):e29-e32. PubMed ID: 34816802
[TBL] [Abstract][Full Text] [Related]
10. PSENEN Mutation Carriers with Co-manifestation of Acne Inversa (AI) and Dowling-Degos Disease (DDD): Is AI or DDD the Subphenotype?
Li C; Li W; Xu H; Zhang X; Su B; Zhang W; Zhang X; Wang B
J Invest Dermatol; 2017 Oct; 137(10):2234-2236. PubMed ID: 28601418
[No Abstract] [Full Text] [Related]
11. Concurrent hidradenitis suppurativa and Dowling-Degos disease taken down a 'Notch'.
McGrath JA
Br J Dermatol; 2018 Feb; 178(2):328. PubMed ID: 29441533
[No Abstract] [Full Text] [Related]
12. Novel POFUT1 mutation associated with hidradenitis suppurativa-Dowling-Degos disease firm up a role for Notch signalling in the pathogenesis of this disorder.
González-Villanueva I; Gutiérrez M; Hispán P; Betlloch I; Pascual JC
Br J Dermatol; 2018 Apr; 178(4):984-986. PubMed ID: 29274243
[No Abstract] [Full Text] [Related]
13. Coexistence of acne inversa with psoriasis and Dowling-Degos disease harboring impaired PSENEN-Notch signaling.
Xiao XM; Zhou PJ; Zhu CH; Lin LH; Liu JJ; Han Y
Chin Med J (Engl); 2020 Oct; 133(19):2383-2385. PubMed ID: 32852387
[No Abstract] [Full Text] [Related]
14. Dowling-Degos disease co-presenting with Darier disease.
Strausburg M; Linos K; Staser K; Mousdicas N
Clin Exp Dermatol; 2016 Jun; 41(4):410-2. PubMed ID: 26685052
[TBL] [Abstract][Full Text] [Related]
15. Novel POFUT1 mutation associated with hidradenitis suppurativa-Dowling-Degos disease firm up a role for Notch signalling in the pathogenesis of this disorder: reply from the authors.
Pavlovsky M; Sarig O; Eskin-Schwartz M; Hafner A; Sprecher E
Br J Dermatol; 2018 Apr; 178(4):986. PubMed ID: 29274076
[No Abstract] [Full Text] [Related]
16. Hidradenitis Suppurativa Associated with Galli-Galli Disease: Extending the Link with Dowling-Degos Disease.
Del Mar M; González M; Sayed C; Phadke P
J Clin Aesthet Dermatol; 2020 Dec; 13(12):38-40. PubMed ID: 33488918
[TBL] [Abstract][Full Text] [Related]
17. [Mutations in presenilin in Dowling-Degos disease: Association with follicular occlusion disorder and the notch-signalling pathway].
Dereure O
Ann Dermatol Venereol; 2017 Dec; 144(12):825-826. PubMed ID: 29100615
[No Abstract] [Full Text] [Related]
18. A novel mutation in POFUT1 gene associated with Dowling-Degos disease and hidradenitis suppurativa.
García-Gil MF; Monte Serrano J; Ramirez-Lluch M; Valero Torres A; López-Giménez MT; Lezcano Biosca V
Int J Dermatol; 2021 Jan; 60(1):e25-e27. PubMed ID: 32767357
[No Abstract] [Full Text] [Related]
19. Altered Notch Signaling in Dowling-Degos Disease: Additional Mutations in POGLUT1 and Further Insights into Disease Pathogenesis.
Ralser DJ; Takeuchi H; Fritz G; Basmanav FB; Effern M; Sivalingam S; El-Shabrawi-Caelen L; Degirmentepe EN; Kocatürk E; Singh M; Booken N; Spierings NMK; Schnabel V; Heineke A; Knuever J; Wolf S; Wehner M; Tronnier M; Leverkus M; Tantcheva-Poór I; Wenzel J; Oji V; Has C; Hölzel M; Frank J; Haltiwanger RS; Betz RC
J Invest Dermatol; 2019 Apr; 139(4):960-964. PubMed ID: 30414910
[No Abstract] [Full Text] [Related]
20. Mutations in POFUT1, encoding protein O-fucosyltransferase 1, cause generalized Dowling-Degos disease.
Li M; Cheng R; Liang J; Yan H; Zhang H; Yang L; Li C; Jiao Q; Lu Z; He J; Ji J; Shen Z; Li C; Hao F; Yu H; Yao Z
Am J Hum Genet; 2013 Jun; 92(6):895-903. PubMed ID: 23684010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
